MECP2 and gestational diabetes: We detected the expression of MeCP2 in the placenta by immunohistochemical experiments, and the results showed that the expression of MeCP2 in the placenta of GDM patients was significantly down-regulated compared with the control group (P<0.05, Figures 4A, B).